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Nitric oxide is unconstrained by cell membranes and can therefore act along a broad
distance as a volume transmitter. Spillover of nitric oxide between neurons may have
a major impact on central nervous system diseases and particularly on neurodegener-
ation. There is evidence whereby communication between nitrergic and dopaminergic
systems plays an essential role in the control of the nigrostriatal pathway. However, there
is sparse information for either the coexistence or overlap of nitric oxide and dopaminergic
structures. The dual localization of immunoreactivity for nitric oxide synthase (NOS) and
tyrosine hydroxylase, enzymes responsible for the synthesis of nitric oxide and dopamine,
respectively, was examined in neurons of the nigrostriatal pathway in the rat brain by
means of a double-immunohistochemical method and confocal laser scanning microscopy,
acquired at the resolution limit. After perfusional fixation, the brains were cut and double-
immunostained. A proximity analysis of tyrosine hydroxylase and NOS structures was done
using binary masks generated from the respective maximum projections, using confocal
laser microscopy. Unrevealed regions were determined somatodendritic positive for both
NOS and tyrosine hydroxylase, within an image limit resolution at 2µm-wide margin. The
described interconnected localization of nNOS(+) andTH(+) containing neuronal fibers and
cells bodies in the nigrostriatal pathway propose a close anatomical link between the two
neurotransmitters.
Keywords: dopamine, nitric oxide synthase, Parkinson disease, volume transmission, neurotransmitter spillover,
synapse, plasticity, tyrosine hydroxylase
INTRODUCTION
The mammalian basal ganglia (also referred to as caudate–
putamen or neostriatum) are a group of subcortical nuclei impli-
cated in a multiplicity of functions including motor, cognitive,
and mnemonic behaviors (Bolam et al., 2000; Graybiel, 2000;
Gerfen and Surmeier, 2011). The response of the basal ganglia
circuitry to cortical stimuli is modulated by the neurotransmit-
ter dopamine (Shen et al., 2008). Dopamine is crucial to motor,
motivational, and reward-related functions of the central nervous
system (Bolam et al., 2000; Graybiel, 2000). Degeneration of the
dopamine system causes neurological disorders such as Parkin-
son’s disease and is involved in multisystem atrophy (Haavik and
Toska, 1998; Nagatsu and Ichinose, 1999; Benavides-Piccione and
DeFelipe, 2003).
Abbreviations: 6-OHDA, 6-hydroxy-dopamine; CLSM, confocal laser scanning
microscopy; CY3, cyanine-3; DA, dopamine; FITC, fluorescein isothiocyanate;
GABA, gamma-aminobutyric acid; l-NAME, NG-nitro- l-arginine methyl ester;
NADPH, nicotinamide adenine dinucleotide phosphate; NMDA, N -Methyl-d-
aspartate acid; nNOS, neuronal nitric oxide synthase; NOS, nitric oxide synthase;
TH, tyrosine hydroxylase.
In addition to releasing dopamine from nerve terminals in
striatum, nigrostriatal dopamine neurons synthesize and release
dopamine from the soma and dendrites Geffen et al., 1976; Paden
et al., 1976; Nieoullon et al., 1977; Wilson et al., 1977; Heeringa
and Abercrombie, 1995). The molecular mechanisms underlying
the modulatory role of dopamine on striatal and consequently
on cortical transmission occur mostly by somatodendritic release
(Gonon, 1997; Cragg and Rice, 2004; Rice and Cragg, 2004; see
Figure 1). Geffen et al. (1976) suggested that the process of soma-
todendritic dopaminergic release is vesicular and exocytotic, like
axonal release (see Figure 1). The release of a single vesicle of
dopamine could modulate the excitability of tens to thousands of
synapses within a few micrometers of a release site, in both sub-
stantia nigra compacta and striatum (Cragg et al., 2001; Rice and
Cragg, 2008). It has been proposed that the sphere-of-influence
of dopamine spillover in a concentration sufficient to stimulate
dopamine receptors, has a radius of 2–8µm (Rice and Cragg, 2008;
see also Gonon, 1997; Cragg and Rice, 2004; Arbuthnott and Wick-
ens, 2007). In addition, there is evidence for a lack of post-synaptic
specialization at 60–70% of suggested dopamine release sites in the
striatum (Descarries et al., 1996) and limited evidence for either
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FIGURE 1 | Schematic representation of the main sources of volume
transmission involving dopamine and nitric oxide signals in the central
nervous system (Inspired by Zoli et al., 1999; Syková, 2004). (A) Synaptic
transmission: Synaptic vesicular release followed by the diffusion of the
transmitter outside the synaptic cleft at an effective concentration.
Neurotransmitters can escape from the synaptic cleft (especially during
repetitive stimulation and/or the massive release of a transmitter) and affect
extrasynaptic receptors on glia or neurons or reach a neighboring synapse.
These phenomena have been called “transmitter spillover” and “synaptic
crosstalk.” This loss of synaptic independence means that transmitter release
at one synapse can lead to the activation of receptors in nearby synapses. (B)
Volume transmission: vesicular release from non-junctional varicosities, i.e.
varicosities lacking pre-synaptic specializations and post-synaptic densities.
Axons both in the central nervous system and in the autonomic nervous
system form varicose (boutons-en-passant ) branches that may release and
uptake neurotransmitters. The transmitter release from varicosity without
synaptic contact diffuses far away from the release site and activates remote
receptors of high affinity. (C,D) Release of gaseous transmitters, e.g. nitric
oxide release from neurons. The inside cell squares are representative of a
local synthesis of the neurotransmitter, frequently by enzymatic regulated
activity. Nitric oxide presumably operates within a 3-dimensional volume of
tissue rather than, more conventionally, between immediately adjacent
cellular partners (Kiss and Vizi, 2001). Glu, glutamate vesicles; NOS, nitric
oxide synthase; NO, nitric oxide; NMDA, N -Methyl-d-Aspartate.
pre- or post-synaptic specializations to delineate somatodendritic
dopamine release sites in midbrain dopaminergic neurons (Wil-
son et al., 1977). Spillover is required for signaling by dopamine
since its receptors are largely extrasynaptic (Cragg et al., 2004).
This extrasynaptic interaction would be a communication inter-
mediary between classic neurotransmission and the relatively non-
specific neuroendocrine secretion (Agnati et al., 1986, 1995, 2010;
Descarries et al., 1996; Descarries and Mechawar, 2000; Cragg and
Rice, 2004; Bullock et al., 2005; Fuxe et al., 2007, 2010; De-Miguel
and Fuxe, 2012).
Neurochemical and morphological evidence indicate that many
other neurotransmitters may be released from both synaptic and
extrasynaptic sites for diffusion to target cells (Agnati et al., 1986,
1995, 2010; Descarries et al., 1996; Descarries and Mechawar,
2000; Cragg and Rice, 2004; Bullock et al., 2005; De-Miguel
and Trueta, 2005; Fuxe et al., 2007, 2010; De-Miguel and Fuxe,
2012). Dopaminergic signals can be inhibited or enhanced by
a variety of identified factors that regulate axonal and somato-
dendritic dopamine release. Specific factors include dopamine
autoreceptors, Ca2+, glutamate, GABA, acethilcholine, opioids,
cannabinoids, and the diffusible messengers hydrogen peroxide
and nitric oxide (Wightman, 2006; Rice et al., 2011). Recent find-
ings indicate that nitric oxide may be involved in the extrasynaptic
interactions (Figure 1; Kiss and Vizi, 2001; Kiss et al., 2004; Stein-
ert et al., 2008). Volume signaling by nitric oxide is supported
by studies modeling the spread of nitric oxide in space and time
(Philippides et al., 2000). The function of nitric oxide as a “vol-
ume” transmitter has been proposed in systems where the source
and target of nitric oxide are anatomically segregated (Gally et al.,
1990; Wood and Garthwaite, 1994; Philippides et al., 2005; Steinert
et al., 2008). Artinian et al. (2010) support the notion that cellu-
lar nitric oxide release can modulate neuronal firing properties
in synaptically unconnected neurons, in direct support of nitric
oxide functioning as a volume messenger.
Nitric oxide is a gaseous neurotransmitter and an unstable free
radical highly diffusible in aqueous and lipid environments. Nitric
oxide is produced from l-Arginine by nitric oxide synthase (NOS)
after N -Methyl d-Aspartate (NMDA) receptor activation and cal-
cium influx (Snyder and Ferris, 2000; Garthwaite, 2008). Once
inside target cells, nitric oxide binds the iron in the heme group
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contained within the active site of soluble guanylyl cyclase, thereby
activating the enzyme to form cyclic guanosine monophosphate
and other effector enzymes located in pre-synaptic and post-
synaptic elements (Garthwaite and Boulton, 1995; Garthwaite,
2008). Also, nitric oxide can serve as a link between monoamin-
ergic and glutamatergic synaptic extrasynaptic transmission (Kiss
and Vizi, 2001; Vizi et al., 2004).
Given that nitric oxide is freely diffusible and thus can readily
enter adjacent neuronal cells or other cells, NOS enzymatic activ-
ity is exceptionally regulated (Snyder and Ferris, 2000). There are
at least three different forms of this enzyme (Griffith and Stuehr,
1995): the endothelial that is responsible essentially for cardiovas-
cular actions, the inducible form found originally in macrophages
and involved mainly in immune processes and the neuronal NOS
(nNOS), present mostly in neurons but also in mitochondria and
chondrocytes. All NOS contain multiple regulation sites (Grif-
fith and Stuehr, 1995; see also Garthwaite, 2008; Steinert et al.,
2008 for review). Even though nearly all oxidative enzymes employ
one electron donor, NOS is further complexed (Snyder and Ferris,
2000) since it possesses a tightly bound flavin adenine mononu-
cleotide and dinucleotide, in addition to NADPH. It further
utilizes heme and tetrahydrobiopterin as electron donors. NOS
possesses sites for phosphorylation by the major phosphorylating
enzymes, including cyclic AMP-dependent protein kinase, pro-
tein kinase C, calcium-calmodulin-dependent protein kinase, and
cyclic guanosine monophosphate-dependent protein kinase (see
Garthwaite, 2008; Steinert et al., 2008 for review). Hence, NOS
must be activated every time a neuron releases nitric oxide, which
is then released as soon as it is synthesized.
Neuronal NOS is a cytoplasmic enzyme (Garthwaite, 2008)
that is expressed by discreet populations of neurons in the central
nervous system (Vincent and Kimura, 1992). All nNOS interneu-
rons express also nicotinamide adenine dinucleotide phosphate
diaphorase (NADPH-d; Sancesario et al., 2004; see also Rushlow
et al., 1995; Figueredo-Cardenas et al., 1996). Within the striatum,
interneurons expressing nNOS are well characterized by cyto-
chemical and physiological criteria (Kawaguchi, 1993; Kawaguchi
et al., 1995, 1997). nNOS-containing interneurons represent only
about 1% of neuronal cells in the brain (Sancesario et al., 2004;
see also Rushlow et al., 1995; Figueredo-Cardenas et al., 1996).
Because nNOS is not necessarily confined to pre- or post-synaptic
specializations, nitric oxide can potentially be released from exten-
sive extrasynaptic regions of nitrergic neurons (Philippides et al.,
2005). Therefore, the somata and dendrites of nNOS cells represent
potentially large sources of nitric oxide (see Figure 1).
Nitric oxide is an activity-dependent volume modulator, adapt-
ing intrinsic excitability and synaptic efficacy and modulating both
active and inactive neuronal populations to the same physiologi-
cal input (Gally et al., 1990; Philippides et al., 2005; Steinert et al.,
2008). The proximity of the target cells is one factor that will
determine the strength of the nitric oxide signal they receive. Even
if the signal from a single small nitric oxide source is very local,
multiple active sources can cooperate to cover large tissue vol-
umes with nitric oxide concentrations that exceed those generated
at the surface of a singly active source (Philippides et al., 2005).
The proximity of the nitrergic inputs to dopaminergic inputs on
medium spiny neurons in the striatum (Hidaka and Totterdell,
2001) suggests an important role for nitric oxide transmission in
modulating the responsiveness of medium spiny neurons to affer-
ent drive (for review see West et al., 2002). This consideration raises
the possibility that the topography of nNOS-containing cells and
the degree of their overlap with dopaminergic neurons may be of
functional significance.
Dopamine neurons are easily identified by the presence of
TH(+), a rate-limiting enzyme for catecholamine synthesis that
catalyzes the conversion of tyrosine to l-DOPA, the first step in
catecholamine neurotransmitter production (Hökfelt et al., 1976,
1977). TH(+) immunoreactive fibers and neurons are generally
regarded as dopaminergic (Bouyer et al., 1984). In the brain, the
synthetic enzyme for nitric oxide in neurons, the nNOS, is easily
identified (Kawaguchi, 1993; Rushlow et al., 1995; Figueredo-
Cardenas et al., 1996). Abundant evidence indicates interaction
between nitrergic and dopaminergic systems playing an impor-
tant role in the control of motor function and in the context of
neurodegenerative diseases, such as Parkinson’s (Galati et al., 2008;
Gomes et al., 2008) and l-DOPA-induced dyskinesia (Padovan-
Neto et al., 2009, 2011; Novaretti et al., 2010; Yuste et al., 2011;
Takuma et al., 2012; for review see Jenner, 2008; Del Bel et al.,
2011; Iravani and Jenner, 2011; Pierucci et al., 2011; West and
Tseng, 2011; Iravani et al., 2012). A similar localization/interaction
in either neuronal compartment would reinforce the suggestion,
whereby nitric oxide influences the outcome of a movement,
perhaps, opening new strategies for novel therapeutic regimes.
Our aim is to explore the hypothesis that the spatial relation-
ships between either axons or somata of the nitric oxide and
dopaminergic cells may represent selective associations between
the nitrergic and dopaminergic systems. For this purpose, the dual
localization of immunoreactivity for NOS and tyrosine hydroxy-
lase in neurons of the nigrostriatal pathway in the rat brain was
examined by means of a double-immunohistochemical method
and confocal laser scanning microscopy (CLSM).
MATERIALS AND METHODS
ANIMALS
Adult male Wistar rats (200–250 g) were housed in groups of
five per cage in a temperature-controlled room (23˚C), under
12 h light-dark cycles with free access to food and water. Experi-
ments were conducted according to the principles and procedures
described by the Guidelines for the Care and Use of Mammals in
Neuroscience and Behavioral Research (ILAR, USA) and Guide-
lines from the School of Medicine (USP, Brazil). The institutions
housing conditions and experimental procedures were previously
approved by the local Animal Ethics Committee.
TISSUE PROCESSING
Rats were deeply anesthetized with urethane (25 mg/kg) and then
rapidly perfused transcardially with 250 ml of cold saline and
400 ml of 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer
(pH 7.4). Brains were immediately removed and fixed in 4% PFA
for 24 h and cryoprotected in 30% sucrose solution. Brains were
snap frozen in isopenthane (−40˚C, Sigma) and stored at −70˚C
till use. The tissues were cut at 40µm on a cryostat. Sections
through the brain regions were collected in 0.01 M PBS solution
containing 0.02% sodium azide and stored at 4˚C until use.
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IMMUNOHISTOCHEMISTRY REACTION
Herbison et al. (1996) reported the production and specificity
of the K205 sheep anti-rat nNOS antibody and, in particular,
noted that it detects one main protein with a molecular mass of
155 kDa in the rat brain. To assess antibody specificity within the
rat brainstem, liquid phase adsorption experiments were under-
taken in the present study by incubating the K205 at working
dilution (1:5000) with recombinant rat nNOS (1 mM) overnight
at 4˚C and then carrying out immunocytochemistry on brainstem
sections using the adsorbed antiserum in parallel with the normal
K205 (Simonian and Herbison, 1996). These experiments showed
that all immunoreactivity was abolished by adsorption of the K205
antiserum.
Immunohistochemistry was performed using a standard
peroxidase-based method (Gomes et al., 2008). The sections were
incubated with the TH-specific primary antibody (1:2000, Pel
Freez, Rogers, AR, USA) overnight at 4˚C, followed by biotiny-
lated secondary antibody (Vectastain ABC kit, Vector Labora-
tories) and HRP-conjugated streptavidin (Vectastain ABC kit,
Vector laboratories) incubation. The sections were developed
using diaminobenzidine as the chromogen, mounted on slides
and cover slipped for subsequent microscopic observation. Struc-
ture localization was determined with the help of the Paxi-
nos and Watson (1999). Images containing TH immunostaining
were captured with a digital Olympus DP70 camera mounted
on a wide field microscope. Immunoreactive cells in a field of
1.02 mm× 0.78 mm were then counted using the image processing
and analysis software package Image J.
Double-immunolabeling was carried out in the same brain
region to characterize nNOS and TH expression. The sections were
incubated overnight at 4˚C with an anti-TH antibody (1:1000, Pel
Freez, Rogers, AR, USA) followed by a 2 h incubation at room
temperature with a secondary donkey anti-mouse IgG (H+ L)
antibody coupled to Alexa Fluor 488 (1:250; Invitrogen, Scotland,
UK). After TH labeling, the tissue was washed three times with
PBS and incubated overnight with a polyclonal antibody specific
for rat nNOS (1:1000; sheep anti-nNOS, K205, gift of P. Emson,
Cambridge, UK). The primary nNOS antibody was then revealed
with a Cy3-coupled donkey anti-sheep IgG (H+ L; 1:250; Jackson
Immuno Research, USA). The primary antibodies were diluted
in PBS (0.1 M; pH 7.4) containing 0.02% thimerosal, 5% normal
goat serum (NGS, Jackson Immuno Research, USA), 0.2% Triton
X-100, while the secondary antibodies were diluted only in PBS
(0.1 M; pH 7.4).
Controls for the fluorescent double-labeling experiments
involved the omission of one of the primary antibodies in the
presence of the other and both secondary antibodies. In these
experiments, neither Cy3 nor Alexa Fluor 488 staining was appar-
ent on cells when either the TH or the nNOS antiserum was omit-
ted. Double-stained sections were analyzed using a fluorescence
microscopy setup (Nikon, Japan) equipped with a 60x objective
(numerical aperture 1.4) and connected to an image analysis sys-
tem (Mercator, Explora Nova, La Rochelle, France). A total of
six sections of each selected brain region, encompassing rostral,
middle, and caudal levels of the striatum, subthalamic nuclei,
substantia nigra pars compacta and reticulate, ventral tegmental
FIGURE 2 | A schematic illustrating the method used to visualize
processes present in the cell periphery. The cell body (red) was
thresholded (A) to generate a binary mask and then enlarged [blue line in
(B,C)] to occupy an additional 2µm around its periphery. Areas occupied
within the blue periphery by the green processes are shown in [(C,D);
yellow areas]. In (D), only the pixels where processes are within the 2µm
proximity of the cell body are shown. A 2D scatter plot (E) was generated
using Imaris 7.5 (Bitplane) revealing a pixel population (outlined with yellow
line) with correlating intensities (Pearson ∼0.7), out of which a new
channel was generated.
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area, and pedunculopontine nuclei were examined, as previously
described (Debeir et al., 2005).
CELL NUCLEI LABELING
A fluorescent stain that labels DNA and allows for easy visual-
ization of the nucleus in interphase cells and chromosomes in
mitotic cells is 4′,6-diamidino-2-phenylindole (DAPI, Chazotte,
2011). DAPI (10 mg/mL in H2O stock solution; Invitrogen D1306)
was diluted 1:5000 with PBS (DAPI labeling solution). The slides
were incubated for 1–5 min at room temperature in DAPI label-
ing solution. The slides were rinsed three times in PBS+ and the
coverslips mounted (Chazotte, 2011).
CONFOCAL LASER SCANNING MICROSCOPY
Sections double-stained for nNOS and TH were inspected using
a Leica SP2 and Leica SP5 confocal laser scanning microscopes
(both Leica Microsystems, Wetzlar, Germany). Z-stacks of the
frontal cortex were acquired with a 40× oil objective (1.25NA,
HCX PL APO CS), while regions from the striatum and substan-
tia nigra were acquired at the optical resolution limit (43 nm×
43 nm× 130 nm) with a 63× (HCX PL APO) oil objective
and subsequently deconvolved with AutoQuant®X (Ver. X2.2.1,
Media Cybernetics, MD, USA) to obtain an improved signal-
to-noise ratio. The Alexa Fluor 488 fluorophore (Abs= 495 nm,
Em= 519 nm) was excited with the 488 nm laser line of an Ar-laser,
while the Cy3 fluorophore (Abs= 550 nm, Em= 570 nm) was
excited at 561 nm, with emission being collected in a line-by-line
fashion at 500–530 and 570–650 nm, respectively.
TYROSINE HYDROXYLASE AND NITRIC OXIDE SYNTHASE-POSITIVE
STRUCTURES PROXIMITY ANALYSIS
For the ensuing analysis, cells were chosen whose the major, longi-
tudinal axis is orthogonal with respect to the z-axis of the stack. A
maximum intensity projection was then generated with Fiji soft-
ware package (Walter et al., 2010) from the nNOS(+) and TH(+)
channels, respectively, based on a 5µm-thick optical section cen-
tered at the widest z-position of the cell body. Binary masks were
then generated from both maximum projection types (schematic
representation in Figure 2A). Fiji was then used to grow the
binary mask of the cell body such that the resulting area cov-
ered an additional 2µm-wide margin at the periphery of the
nNOS(+) immunoreactive cell body (blue margin in Figure 2B).
The expanded binary mask depicting the cell body was added to
the mask representing the fibrous structures (Figure 2C). In a final
step, pixels within this newly generated margin that were positive
for both, nNOS(+) and TH(+) immunoreactivity were identified
(yellow pixels in Figures 2C,D). Imaris 7.4.2 (Bitplane) was used
to generate 3D representations of the respective z-stacks and for
colocalization analysis (Figure 2E).
RESULTS
Both hemispheres of all animals showed a similar distribution
pattern of the TH(+) and nNOS(+) immunoreactive cells and
fibers within the striatum-nigra pathway. Using CLSM optical
sections acquired at the resolution limit, colocalized regions (Pear-
son correlation coefficient ≥0.7) were identified (yellow). The
yellow pseudo-color for these structures visible in CLSM images
FIGURE 3 | Confocal laser scanning microscopy ofTH(+) and nNOS(+)
double-immunostained sections from the rat cingulate cortex. The
TH(+) immunoreactivity (A,C) is shown in green, whereas the nNOS(+)
immunoreactivity (A,B) is red, in the same double-stained section. In (B,C),
the binary masks of the nNOS(+) andTH(+) signals are shown, respectively,
while (D) additionally shows the 2µm-wide periphery (yellow) of the
nNOS(+) cell body and processes (red). The yellow areas in (E) indicate the
location of TH(+) processes within the 2µm periphery of the nNOS(+) cell.
There is absence of complete colocalization between nNOS(+) and TH(+)
immunoreactivity in the rat cortex but a large number of fibers are present
within the 2µm nNOS(+) cell periphery. Scale bar is 50µm.
could represent the superimposition of TH(+) immunoreactivity
(green) on nNOS(+) immunoreactivity (red) neurons/fibers and
vice versa. Assessment of sections double-stained for nNOS(+)
and TH(+) immunoreactivity revealed a considerable overlap of
their topographies. The distribution of nNOS(+) immunoreac-
tivity is generally in agreement with the data published by others
using either an immunocytochemical (Bredt et al., 1990; Schmidt
et al., 1992; Egberongbe et al., 1994; DeVente et al., 1998) or a his-
tochemical approach (Vincent and Kimura, 1992; Southam and
Garthwaite, 1993).
CORTEX
The prefrontal, anterior cingulate, insular, piriform, perirhinal,
entorhinal, motor, premotor, parietal, temporal, and posterior
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FIGURE 4 | Photomicrographs of nNOS(+) immunoreactive neurons
(A) andTH(+) nerve fibers (B) in sections from the caudate–
putamen/globus pallidus [merge in (C)]. nNOS(+) immunoreactive
neurons appear polygonal or fusiform in shape with long smooth dendrites
and a plexus of nerve fibers in the neuropil. The low-power
photomicrograph shows the intense staining of the TH(+)
immunoreactivity and the large number of nNOS(+) cell body in the caudal
striatum. Scale bar=200µm.
FIGURE 5 | Confocal laser scanning microscopy ofTH(+) and nNOS(+)
immunoreactive double-immunostained sections from the rat striatum.
Fibers immunoreactive for TH(+; green) are presented in (B,C,C′). A neuron
immunoreactive for nNOS(+)(red) is presented in (A,C,C′). Using CLSM
optical sections acquired at the resolution limit, colocalized regions (Pearson
correlation coefficient of ≥0.7) were identified (yellow). The yellow areas in
(C,D,C′) also indicate the location of TH(+) processes within the 2µm
periphery of the nNOS(+) cell. Detail of the cell body is presented in (C′). In
the rat striatum a large number of TH(+) fibers are present within the 2µm
nNOS(+) cell body. Scale bar in (D,C′)=5µm.
cingulate cortices had a dense distribution of TH(+) immunore-
active fibers. A small population of medium-large, intensely
nNOS(+) immunoreactive multipolar neurons was found scat-
tered throughout layers 2–4 of all examined cortices. The reac-
tion product for nNOS(+) immunohistochemistry in the corti-
cal neurons formed dense, conspicuous masses with no nuclei
labeling.
A qualitative analysis of the area 2µm proximal to the
nNOS(+) cell body was carried out (Figure 3) in the anterior cin-
gulate cortex (Bregma 0.797–0.251, Paxinos and Watson, 2009).
The TH(+) immunoreactivity (Figures 3A,C) is shown in green,
whereas the nNOS(+) immunoreactivity (Figures 3A,B) is red,
in the same double-stained section. In Figures 3B,C, the binary
masks of the nNOS(+) and TH(+) signals are shown, respec-
tively. The yellow area in Figure 3D represents the 2µm periphery
of the nNOS(+) cell. Figure 3E shows only areas where the TH(+)
immunoreactive cell body or processes are located within the 2µm
proximity of the nNOS(+) immunoreactive cell body or processes
thereof.
STRIATUM
In general, nNOS(+) immunolabeling was detected in the cyto-
plasmic domains of the cell body and dendrites. The nucleus
was unstained and the reaction product was evenly distributed
in the cytoplasm. A dense network of NOS(+) varicose fibers was
observed in the striatal complex. TH(+) immunohistochemistry
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FIGURE 6 | Confocal laser scanning microscopy ofTH(+) and nNOS(+)
immunoreactive double-immunostained sections from the rat
striatum: a proximity analysis study. Distribution pattern of
immunoreactivity for TH(+) and a nNOS(+) in double-stained sections of
the striatum. Both, nNOS (red) and TH (green) fluorescent signals are
shown in (A), while (B,C) show the corresponding binary masks. The 2µm
periphery (yellow) is shown in (D) and the area occupied by TH(+)
immunoreactive fibers around the nNOS(+) immunoreactive cell body is
shown in (E). The yellow areas in E indicate the location of TH(+) and
nNOS(+) possible interaction. Scale bar in (A) is 10µm.
demonstrated TH(+) immunoreactive terminals or varicose fibers
in the neuropil of the striatum (Figures 4, 6C, and 8D).
TH(+) immunolabeling in the striatum appeared as a dense,
inhomogeneous plexus of fibers with an absence of cell bodies
at any level (see Moss and Bolam, 2008). Several punctate struc-
tures (Figures 5C,C′,D and 6D,E; yellow dots) showing TH(+)
immunoreactivity and nNOS(+) were in close contact. They
were surrounding either the cell bodies or the cell processes (see
Figures 5 and 6). The yellow areas in Figures 5C,D,C′ also indi-
cate the location of TH(+) processes within the 2µm periphery
of the nNOS(+) cell. Detail of the cell body is presented in
Figure 5C′.
The nucleus accumbens (ventral striatum) displayed TH(+)
immunoreactivity and nNOS(+) immunoreactivity similar to that
FIGURE 7 |The fluorescence pattern in a double-stained section of the
nucleus accumbens, showing nNOS(+) [(A,C) – cell body) andTH(+)
[(B,C) axons] immunoreactivities. Immunoreactivity for TH(+) and a
nNOS(+) in double-stained sections of the nucleus accumbens. Both,
nNOS (red) and TH (green) fluorescent signals are shown in (C). Whereas
the TH(+) fiber immunoreactivity appears homogeneously distributed
throughout the whole nuclei, the nNOS(+) immunoreactive neurons and
fibers are stained much more sparsely. Scale bar in (A)=10µm, it applies
to (B,C) also.
of the dorsal striatum (Figure 7). There was a range of nNOS(+)
cell body shapes, from which two to four smooth and extensive,
poorly branching dendrites emanated, similar to those described
by Hussain et al. (1996). The nNOS(+) immunoreactive cells were
of medium size, fusiform and spiny interneurons with long, poorly
branched dendrites that comprise only a small percentage of the
striatal neuronal population.
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FIGURE 8 | Internal globus pallidus [entopeduncular nucleus-(A,B),
merge in (C)] and external globus pallidus (D) photomicrographs of
nNOS(+) immunoreactive neurons andTH(+) nerve fibers. (A–C) TH(+)
and nNOS(+) immunoreactive fiber staining representative of the typical
honeycomb-like pattern in the entopeduncular nucleus [merge in (C)]. TH(+)
immunoreactivity corresponds to the medial forebrain bundle. (D)
Photomicrography of nNOS(+) immunoreactive neurons and TH(+) nerve
fibers (merge) from a section of the external globus pallidus/caudal
striatum. Note the nNOS(+) immunoreactive cells (red), the dark staining
surrounds areas of lighter immunoreactivity (external globus pallidus) and
the dense TH(+) fibers in the striatum. nNOS(+) immunoreactive neurons
appear polygonal in shape with long smooth dendrites and a plexus of
nerve fibers in the neuropil. Scale bars, 100µm.
GLOBUS PALLIDUS EXTERNAL AND INTERNAL (ENTOPEDUNCULAR
NUCLEI)
The TH(+) and nNOS(+) immunoreactivity double-labeling in
the pallidus external and internal (entopeduncular nucleus in the
rat) is presented in Figures 8 and 9. In the internal globus pallidus
we observed clusters of numerous NOS(+) cell bodies. TH(+)
and nNOS(+) immunoreactivity in the fiber staining represent a
typical honeycomb-like pattern (Figure 8). TH(+) immunoreac-
tivity corresponds to the medial forebrain bundle. In Figure 8D,
note the nNOS(+) immunoreactive cells (red) in the external
globus pallidus and the less intense staining surrounding areas
of lighter immunoreactivity. nNOS(+) immunoreactive neurons
appear polygonal in shape with long smooth dendrites and a plexus
of nerve fibers in the neuropil.
In the external globus pallidus (Figures 8D and 9), there is
a distinct punctuate pericellular nNOS(+) labeling of the whole
neuronal soma and dendritic/axonal processes (Figure 9). TH(+)
fibers make multiple contacts onto the nNOS(+) immunoreactive
delineated structure. Using CLSM, zones of cellular colocalization
were ascertained (yellow, Figures 9C,D).
SUBSTANTIA NIGRA/VENTRAL TEGMENTAL AREA
Most TH(+) immunoreactivity is grouped in the substantia nigra
pars compacta, where it is spread forming a dense band that
lies dorsally from the ventral tegmental area (see Figure 10).
In the substantia nigra pars reticulata particularly in its medial
two-thirds, a few TH(+) immunoreactive cells are present, some
FIGURE 9 | Confocal laser scanning microscopy of the external globus
pallidus inTH(+) and nNOS(+) immunoreactive
double-immunostained sections. The axons are immunoreactive for
TH(+) [green, (B,C)] and the neurons/axons immunoreactive for NOS(+)
[(A,C), red] in double-stained sections of the external globus pallidus. Both,
TH(+) and nNOS(+) immunoreactivities are presented in (C). Observe the
lower fluorescence of nNOS(+) immunoreactive cells surrounded by areas
of lighter immunoreactivity of the TH(+)fibers. The nNOS(+)
immunoreactivity delineating a neuronal cell body structure is covered by
dots of TH(+) immunolabeling in yellow (C,D). Using CLSM, zones of
cellular colocalization were ascertained [yellow, (C,D)]. Scale bar is 25µm.
of them arranged in linear bridges which cross the substantia
nigra pars reticulata perpendicularly to the substantia nigra pars
compacta (see Figure 10B). nNOS(+) immunoreactive neurons
appear occasionally in the substantia nigra pars compacta, stained
much more sparsely, with long smooth dendrites (Figures 10A,B).
In the substantia nigra pars compacta we found a dense pat-
tern of TH(+) immunoreactive cells and fibers next to a small
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number of fibers and cell somata with strong NOS(+) immunore-
activity (Figures 10A,B). A double-labeled cell is visualized in
Figure 10C but cell colocalization between nNOS(+) and TH (+)
immunoreactivity is almost absent.
TH(+) immunoreactive and NOS(+) immunoreactive cells
could be observed adjacent to each other, with areas of perfect
match (Figure 11). Fibers and cell bodies are in close proxim-
ity (Figure 11). Figure 11 presents in further detail a nNOS(+)
immunoreactive neuron surrounded by TH(+) immunoreactive
fibers. The yellow area in Figure 11D represents the 2µm periph-
ery of the nNOS(+) neuron. In a further step, the area within this
2µm periphery is visualized, where TH(+) processes are present
(Figure 11E). Zones of colocalization were demonstrated in a sin-
gle optical section of the substantia nigra compacta acquired at
the resolution limit. Actual colocalization between the two mark-
ers was rarely observed. In Figure 11E the area occupied by the
TH(+) processes within the 2µm proximity is visualized.
SUBTHALAMIC NUCLEUS
Functional importance of the subthalamic nucleus neurons is
reflected by its anatomical connections to the main output nuclei
of the basal ganglia, including both segments of the globus pal-
lidus and the substantia nigra. In the subthalamic nucleus we
observed numerous NOS(+) immunoreactive cell bodies and
an intense pattern in the TH(+) immunoreactive fiber stain-
ing (Figure 12), corresponding to the medial forebrain bundle.
nNOS(+) immunoreactive neurons appear massively at the sub-
thalamic nuclei with long smooth dendrites. A very small pro-
portion of subthalamic nucleus neuronal somata were apposed
by immunoreactive axons (Figure 12-insect). The cell nuclei are
labeled with DAPI. Colocalization between the two markers was
almost absent.
PEDUNCULOPONTINE TEGMENTAL NUCLEUS
The pedunculopontine tegmental nuclei are a loosely defined
aggregate of cholinergic and non-cholinergic neurons in
the midbrain which neurons project to substantia nigra
compacta dopaminergic neurons. Our observations revealed
clusters of intensely labeled NOS(+) immunoreactive neu-
rons (Figures 13A,C) and TH(+)immunoreactive fibers
(Figures 13B,D) in the pedunculopontine tegmental nucleus
(Figure 13). Double-labeling experiments indicate that the major-
ity of TH(+) immunoreactive neurons in the pedunculopon-
tine tegmental nucleus did not express NOS(+) immunoreac-
tivity. However, fibers and cell bodies are in close proximity
(Figure 13D).
DISCUSSION
We compared the spatial relationship between dopaminergic and
nitrergic nigrostriatal fibers/cell body through the dual localiza-
tion of the immunoreactivity for nNOS(+) and TH(+). The
approach was based on double-immunohistochemical staining
method using CLSM optical sections acquired at the resolution
limit. A proximity analysis of TH(+) and nNOS(+) structures
was done using binary masks generated from the respective maxi-
mum projections and revealed regions positive for both, nNOS(+)
FIGURE 10 |The substantia nigra compacta and ventral tegmental area
nNOS(+) andTH(+) immunoreactive neurons and fibers. Distribution
pattern of axons/cells immunoreactive for nNOS(+) (A) and TH(+) (B) in
double-stained sections of the substantia nigra [(C), merge]. Cell nuclei are
labeled in blue with DAPI. Using CLSM (A–C), zones of cellular
colocalization were demonstrated in a single optical section of the
substantia nigra compacta [(C), scale bar is=5µm]. Observe the dense
staining of the TH(+) immunoreactive cells and fibers homogeneously
distributed throughout the substantia nigra compacta and the ventral
tegmental area (A). In the substantia nigra, dopaminergic cells are arranged
in two bands (Fallon and Loughlin, 1995). The substantia nigra reticulate
caudoventral emits cell bridges that make contact with the substantia nigra
compacta rostrodorsal [González-Hernández and Rodríguez, 2000; (A,B)].
The substantia nigra compacta is characterized by a high density of
dopaminergic somata as well as a dense network of overlapping
dopaminergic dendrites. Scattered neurons in both substantia nigra
compacta and reticulata display immunoreactivity to nNOS [Rodrigo et al.,
1994; (A,B)]. Cell colocalization between nNOS(+) and TH (+)
immunoreactivity is almost absent but a double-labeled cell is visualized in
(C). Scale bars, 50µm (A–C).
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FIGURE 11 | Substantia nigra compacta nNOS(+) immunoreactive
neuron andTH(+) fibers. CLSM analysis of a double-immunostained
section. (A) Show in detail a nNOS(+)immunoreactive neuron (red)
surrounded by TH(+) immunoreactive fibers (green). (B,C) Show the binary
masks of the TH(+) and nNOS(+) stains, respectively. In (D), the 2µm
proximity of the nNOS(+) cell is shown, while in (E) the area occupied by
the TH(+) processes within the 2µm proximity is visualized. Zones of
colocalization were demonstrated in a single optical section of the
substantia nigra compacta acquired at the resolution limit. Scale bar 10µm.
and TH(+) immunoreactivity, within a 2µm-wide margin. Colo-
calized regions were identified with a Pearson correlation coef-
ficient ≥0.7. A large proportion of nNOS(+) immunoreactive
soma/axon/dendrite themselves were directly apposed by TH(+)
immunoreactive ones, within a radius of 1 and 2µm.
In the dopaminergic synapses, dopamine is released from pre-
synaptic structures by exocytose, binds post-synaptic receptors
and generates pre- and post-synaptic cascades of events (Bertorello
et al., 1990; Beckstead et al., 2004; Jorgensen, 2004; Yao et al., 2008).
FIGURE 12 | Subthalamic nuclei of a control rat brain: distribution
pattern of axons/cells immunoreactive forTH(+; green) and NOS(+;
red) in double-stained sections. The cell nuclei are labeled with DAPI.
Observe the dense staining of the TH(+) immunoreactive fibers of the
medial forebrain bundle (green fibers). nNOS(+) immunoreactive neurons
appear massively at the subthalamic nuclei with long smooth dendrites. The
area occupied by TH(+) immunoreactive fibers around the nNOS(+)
immunoreactive cell body is shown in the inset. Cell colocalization between
nNOS(+) and TH (+) immunoreactivity is absent. Scale bar is 100µm.
The discovery that dopamine is located not only in the terminals
but also in perikarya and dendrites of nigrostriatal neurons led to
the suggestion that dopamine may be released from dendrites in
the substantia nigra (Bjorklund and Lindvall, 1975; more informa-
tion in the review from Trueta and De-Miguel, 2012). Subsequent
immunohistochemical investigations have confirmed that the syn-
thesizing enzymes (Tyrosine hydroxylase), for this catecholamine
are also present in the dendrites of these neurons, some of which
extend ventrally into the substantia nigra pars reticulata (Hökfelt
et al., 1984; Jaeger et al., 1984). Release of dopamine from cell bod-
ies and dendrites is typically referred to as somatodendritic release.
Somatodendritic release of dopamine in the substantia nigra com-
pacta and axonal dopamine release in the dorsal striatum are
both necessary for the expression of basal ganglia-mediated motor
behaviors and various cognitive functions. Dendritically released
dopamine may modulate striatal outflow and thereby play an
important role in basal ganglia function (Robertson and Robert-
son, 1987). Nigral dopamine neurons do not only release their
transmitter into the striatum, but also interact with each other
through release of dopamine from their somata and dendrites
(Centonze et al., 2003; Rice and Cragg, 2004, 2008; complementary
information in the review from Trueta and De-Miguel, 2012).
As described by Cragg and Rice (2004), the sphere-of-influence
of dopamine spillover in a concentration adequate to stimulate
dopamine receptor has a radius of 2–8µm (see also Gonon, 1997;
Arbuthnott and Wickens, 2007; Moss and Bolam, 2008; Rice and
Cragg, 2008). Dopaminergic boutons correspond to almost 10%
of all striatal synapses (Groves et al., 1994; Kreitzer, 2009), and
the nearest-neighbor space among dopaminergic boutons is only
1.18µm (Arbuthnott and Wickens, 2007; Kreitzer, 2009).
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FIGURE 13 | Confocal laser scanning microscopy of the
pedunculopontine nuclei in aTH(+) and nNOS(+)
double-immunostained section. Distribution pattern of axons/cells
immunoreactive for TH(+) [green in (B,C)] and NOS(+) [red in (A,C)] is
presented in this double-stained section. Observe the nNOS(+)
immunoreactive neurons surrounded by sparse TH(+) fibers. TH(+)
immunoreactive fibers appear scattered all around the cell soma. Scale bar
50µm. Scale bar in (D) is 5µm.
Nitric oxide at high concentrations can be used to mediate phys-
iological responses in a restricted area over short periods (Kiss and
Vizi, 2001; Kiss et al., 2004). It is predicted that the physiological
volume of influence of a single source of nitric oxide that emits
for 1–10 s has a diameter (in theory) of about 20 mm, correspond-
ing to a volume of brain enclosing two million synapses (Wood
and Garthwaite, 1994). Tornieri and Rehder (2007) demonstrated
that nitric oxide has physiological effects at distances of up to
100µm (Tornieri and Rehder, 2007). It was described by Ignarro
(2010) that nNOS(+) immunoreactive neurons in the microen-
vironment could accomplish nitric oxide levels 100 times higher
than required to stimulate for example, vasorelaxation of vascu-
lar smooth muscle cells. As described by Garthwaite and Boulton
(1995), nitric oxide generated at a single point source should be
able to influence function within a sphere with a diameter of 300–
350µm, even with a half-life of a few seconds, which is very large
compared with the dimensions of a synapse. Taking into account
some of the known radical scavenging properties of the tissues,
Beckman and Koppenol (1996) reported the approximate ranges
of diffusion for nitric oxide to be approximately 130µm (Bidmon
et al., 2001). Since medium-sized neurons are usually 10–25µum
in diameter, it becomes obvious that nitric oxide may diffuse into
many cells
Therefore, our findings demonstrated that every nitric oxide
molecule will be within overlapping spheres-of-influence of
synaptically released dopamine in all the analyzed brain regions.
Nitric oxide structures are likely to be within reach of a concen-
tration of dopamine that is high enough to stimulate both high
and low affinity receptors (Rice and Cragg, 2008). The topography
of nNOS(+) and TH(+) immunoreactive cells and the degree of
their overlap may be of functional significance.
Our observations are in agreement with Fujiyama and Masuko
(1996); Simonian and Herbison (1996); DeVente et al. (2000);
Hidaka and Totterdell (2001); Benavides-Piccione and DeFelipe
(2003). In many cases, nitrergic terminals are closely apposed
to TH(+) immunoreactive neuronal endings and both converge
onto dendrites of spiny neurons (Hidaka and Totterdell, 2001).
Alternatively, TH(+) immunoreactive neurons form direct synap-
tic contacts with nNOS(+) immunoreactive neurons (Hidaka
and Totterdell, 2001). Fujiyama and Masuko (1996) simultane-
ously demonstrated NADPH-d reactivity and TH(+) immunore-
activity within the same section of the rat striatum using elec-
tron microscopy. Symmetrical and asymmetrical synaptic con-
tacts were found on cell bodies and proximal dendrites. Other
extrasynaptic TH(+) immunoreactive boutons were occasionally
associated with unlabeled terminals adjacent to the NADPH-d
positive dendrites (Fujiyama and Masuko, 1996). Double-labeling
techniques showed that a small population of NOS(+) neurons
in the medulla also contained immunoreactivity to the amin-
ergic neuron marker TH (Dun et al., 1994). Also, occasionally
double-labeling for nNOS(+) and TH(+) could be observed in
some neurons in rat primary mesencephalic cultures (Salum et al.,
2008). In contrast, Klejbor et al. (2004) found numerous TH(+)
and NOS(+) immunoreactive neurons in the ventral tegmental
area. The presence of nNOS(+) immunoreactive cell staining in
the rat entopeduncular nucleus, with typical honeycomb-like pat-
tern in the nucleus was hardly ever described before (Del Bel
et al., 2011). Most frequently, in the external globus pallidus, the
presence of nNOS(+) neurons was described as almost absent.
However, in the external globus pallidus, we observed nNOS(+)
immunoreactivity, with a distinct punctuate pericellular labeling
which seems to correspond to the neuronal soma and/or den-
dritic/axonal processes. TH(+) fibers make multiple contacts onto
the nNOS(+) immunoreactive delineated structure. It is curious
that Arellano et al. (2004) and Castro et al. (2011) have shown
similar pericellular pattern of parvalbumin-positive labeling cells
in the hippocampus of epileptic patients.
These anatomical arrangements facilitate nitric oxide-mediated
modulation of pre- and post-synaptic events such as dopamine
release (Hanbauer et al., 1992; Sancesario et al., 2000; West and
Grace, 2000; DiGiovanni et al., 2003; DiMatteo et al., 2009; Park
and West, 2009). Studies showing that nNOS(+) immunoreac-
tive interneurons facilitate the concurrent release of dopamine
and glutamate by a nitric oxide-dependent process (West and Gal-
loway, 1997; West and Grace, 2000; Park and West, 2009), suggest
that nitric oxide might contribute in the integration of convergent
motor information in striatal networks (West and Grace, 2000). As
gap junction permeability between medium-sized, densely spiny
neurons can be modulated by dopamine in the nucleus accum-
bens (O’Donnell and Grace, 1993), and by nitric oxide in the
dorsal striatum (O’Donnell and Grace, 1997), these inputs may
act together to modulate activities of individual projection neu-
rons by means of conventional chemical synapses,or may influence
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electrotonic transmission between networks of neurons connected
by gap junctions.
Consequently, even though we generally did not find soma
colocalization in the analyzed regions, the implications of this
finding are far-reaching. The ultimate distribution of dopaminer-
gic and nitrergic structures in the nigro-striatal pathway is unlikely
to be a targeted phenomenon, suggesting that the populations
of TH(+) and NOS(+) immunoreactive neurons interact with
each other in all analyzed regions. Together, our observations
corroborate evidence of dopamine and nitric oxide being inter-
twined in the anatomy in addition to physiology and pathology
of the nigrostriatal pathway (Del Bel et al., 2005, 2011; Jenner,
2008; Pierucci et al., 2011; West and Tseng, 2011; Iravani et al.,
2012).
Nitric oxide (Calabresi et al., 1999) and dopamine (Calabresi
et al., 2000) are essential for the expression of synaptic plasticity,
although the effects of nitric oxide may not be restricted to synap-
tic release sites. nNOS(+) interneurons, via nitric oxide release,
have a strong impact on corticostriatal information processing
since they exert a modulatory influence on medium spiny neu-
rons (Sardo et al., 2002; West and Grace, 2004) and control the
induction of long term depression in medium spiny neurons (Cal-
abresi et al., 1999; Sergeeva et al., 2007). Moreover, nitric oxide
acts as a volume transmitter regulating post-synaptic excitability
at glutamatergic synapses (Steinert et al., 2008). Nevertheless, the
molecular mechanisms of the interactions between the nitric oxide
and dopaminergic systems have not been precisely clarified.
Neuromodulators including, nitric oxide play important roles
in the physiology of striatal neurons. However, what is the role
of the interaction between nitric oxide and dopamine? In the
striatum, nitric oxide production has been linked to increased
oxidative damage and to both, necrotic and apoptotic neuronal
death (Brown and Borutaite, 2002; Kim and Koh, 2002; Ischi-
ropoulos and Beckman, 2003; Przedborski et al., 2003; for a recent
review see Brown, 2010). Since dopamine like nitric oxide is redox
active (Przedborski et al., 2003), the production of nitric oxide
within a TH(+) immunoreactive neuron may provide a unique
vulnerability of this cellular subtype compared to other TH(+)
immunoreactive neurons that also do not express nNOS(+). On
the other hand, cellular nitric oxide demonstrated neuroprotective
effects (Wink et al., 1998; Mohanakumar et al., 2002; Sancesario
et al., 2004).
The interrelated localization of nNOS(+) and TH(+) contain-
ing fibers and cells bodies in the nigrostriatal pathway propose an
anatomical link between the two neurotransmitters. Nitric oxide
in combination with dopamine may represent suitable targets
for therapeutic intervention in neurodegenerative diseases as for
example Parkinson’s (for review see Przedborski et al., 2003; Del
Bel et al., 2005, 2011; Pierucci et al., 2011; West and Tseng, 2011).
The success of this type of strategy is well documented in Padovan-
Neto et al. (2009, 2011), Novaretti et al. (2010), Brzozowski et al.
(2011), Takuma et al. (2012), and in the recent reviews (Del Bel
et al., 2005, 2011; Jenner, 2008; Pierucci et al., 2011; West and
Tseng, 2011; Iravani et al., 2012). Future studies will be required to
understand how these two factors interact to regulate basal ganglia
circuit function.
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